USPSTF Recommendation Against Pancreatic Cancer Screening in Asymptomatic Adults

This week, we review the U.S. Preventive Services Task Force (USPSTF) recommendation against screening for pancreatic cancer in adults with no symptoms. We also talk about the discovery of a germline mutation that has been newly associated with pancreatic cancer. Lastly, we discuss a U.S. Food and Drug Administration review which concluded a common Parkinson’s disease drug does not contribute to the development of prostate cancer.

Coverage of stories discussed this week on ascopost.com:

USPSTF Recommendation on Screening for Pancreatic Cancer in Asymptomatic Adults

Germline RABL3 Mutation May Increase Risk of Pancreatic Cancer Development

FDA Review Finds No Increased Risk of Prostate Cancer With Parkinson's Disease Treatments Containing Entacapone